Targeting estrogen receptor mutations for treatment of endocrine therapy resistance in breast cancer

被引：0
|
作者：
Alluri, P. G. [1 ]
Larios, J. M. [1 ]
Malik, R. [1 ]
Hayes, D. F. [1 ]
Speers, C. W. [1 ]
Rae, J. M. [1 ]
Chinnaiyan, A. M. [1 ]
机构：
[1] Univ Michigan, Sch Med, Ann Arbor, MI USA
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P6-12-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-12-05
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Role of IL-6 in promoting endocrine therapy and palbociclib resistance estrogen receptor positive breast cancer cells
    Kettner, Nicole M.
    Bui, Tuyen
    Chen, Xian
    Hunt, Kelly K.
    Tripathy, Debu
    Keyomarsi, Khandan
    CANCER RESEARCH, 2020, 80 (04)
  • [42] Estrogen Receptor Pathway Activity Score to Predict Clinical Response or Resistance to Neoadjuvant Endocrine Therapy in Primary Breast Cancer
    Inda, Marcia A.
    Blok, Erik J.
    Kuppen, Peter J. K.
    Charehbili, Ayoub
    den Biezen-Timmermans, Eveline C.
    van Brussel, Anne
    Fruytier, Sevgi E.
    Kranenbarg, Elma Meershoek-Klein
    Kloet, Susan
    van der Burg, Bart
    Martens, John W. M.
    Sims, Andrew H.
    Turnbull, Arran K.
    Dixon, J. Michael
    Verhaegh, Wim
    Kroep, Judith R.
    van de Velde, Cornelis J. H.
    van de Stolpe, Anja
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (02) : 680 - 689
  • [43] Subsequent endocrine therapy after becoming to resistance of 'estrogen therapy' is beneficial as a salvage treatment for the late stage metastatic breast cancer
    Iwase, H.
    Yamamoto, Y.
    Yamamoto-Ibusuki, M.
    Murakami, K-I
    Inao, T.
    Okumura, Y.
    Omoto, Y.
    CANCER RESEARCH, 2013, 73
  • [44] Estrogen receptor downregulators: New options in endocrine therapy for advanced breast cancer - Introduction
    O'Shaughnessy, J
    Bhardwaj, S
    CLINICAL THERAPEUTICS, 2002, 24 : A1 - A2
  • [45] Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer
    Neupane, Niraj
    Bawek, Sawyer
    Gurusinghe, Sayuri
    Ghaffary, Elham Moases
    Mirmosayyeb, Omid
    Thapa, Sangharsha
    Falkson, Carla
    O'Regan, Ruth
    Dhakal, Ajay
    CANCERS, 2024, 16 (03)
  • [46] Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy
    Kuukasjarvi, T
    Kononen, J
    Helin, H
    Holli, K
    Isola, J
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (09) : 2584 - 2589
  • [47] Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer
    McDonnell, Donald P.
    Wardell, Suzanne E.
    Norris, John D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (12) : 4883 - 4887
  • [48] Role of mitochondria and glutamine metabolism in therapy resistance: Combined targeting of estrogen receptor alpha and exportin 1 in endocrine resistant breast cancers
    Cotul, Eylem Kulkoyluoglu
    Smith, Brandi Patrice
    Chang, Hua
    Landesman, Yosef
    Duong, Kevin
    Erdogan, Zeynep Madak
    CANCER RESEARCH, 2019, 79 (13)
  • [49] Rational Management of Endocrine Resistance in Breast Cancer A Comprehensive Review of Estrogen Receptor Biology, Treatment Options, and Future Directions
    Hurvitz, Sara A.
    Pietras, Richard J.
    CANCER, 2008, 113 (09) : 2385 - 2397
  • [50] Most recent strategies targeting estrogen receptor alpha for the treatment of breast cancer
    Kumar, Nitish
    Gulati, Harmandeep Kaur
    Sharma, Aakriti
    Heer, Shilpa
    Jassal, Anupmjot Kaur
    Arora, Lovenish
    Kaur, Simranpreet
    Singh, Atamjit
    Bhagat, Kavita
    Kaur, Arshmeet
    Singh, Harbinder
    Singh, Jatinder Vir
    Bedi, Preet Mohinder Singh
    MOLECULAR DIVERSITY, 2021, 25 (01) : 603 - 624
12345